Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Dry Eye

1-methyl-3-isobutylxanthine has been researched along with Dry Eye in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilbard, JP1
Rossi, SR1
Heyda, KG1
Dartt, DA1

Trials

1 trial available for 1-methyl-3-isobutylxanthine and Dry Eye

ArticleYear
Stimulation of tear secretion and treatment of dry-eye disease with 3-isobutyl-1-methylxanthine.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1991, Volume: 109, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Administration, Topical; Adult; Aged; Aged, 80 and over; Dose-Response

1991